Plus Therapeutics Stock (NASDAQ:PSTV), Quotes and News Summary

Q: What sector and industry does Plus Therapeutics (PSTV) operate in?

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Plus Therapeutics Stock (NASDAQ: PSTV) stock price, news, charts, stock research, profile.

Open	$1.735
Close	$1.691
Volume / Avg.	7.246K / 28.826K
Day Range	1.687 - 1.790
52 Wk Range	0.969 - 5.100
Market Cap	$7.359M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	34
Short Interest	1.08%
Days to Cover	1.8

Recent News

Insiders Buying Plus Therapeutics And 2 Other Stocks Under $2

The Dow Jones closed lower by around 40 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Lisa Levin

Why Plus Therapeutics Stock Popped Today

PLUS THERAPEUTICS, Inc. (NASDAQ: PSTV) shares are trading higher on Wednesday.

Ryan Gustafson

Why Extreme Networks Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Gainers

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Plus Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focuses on the discove...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Plus Therapeutics (PSTV) stock?

You can purchase shares of Plus Therapeutics (NASDAQ: PSTV) through any online brokerage.

View our list of the best stock brokerages.

Who are Plus Therapeutics's (PSTV) competitors?

Other companies in Plus Therapeutics’s space includes: Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX), Longeveron (NASDAQ:LGVN) and Trevena (NASDAQ:TRVN).

What is the target price for Plus Therapeutics (PSTV) stock?

The latest price target for Plus Therapeutics (NASDAQ: PSTV) was reported by HC Wainwright & Co. on Tuesday, August 15, 2023. The analyst firm set a price target for 8.00 expecting PSTV to rise to within 12 months (a possible 373.37% upside). 5 analyst firms have reported ratings in the last year.

Current Stock Price for Plus Therapeutics (PSTV)?

The stock price for Plus Therapeutics (NASDAQ: PSTV) is $1.69 last updated April 18, 2024 at 4:40 PM EDT.

Does Plus Therapeutics (PSTV) pay a dividend?

There are no upcoming dividends for Plus Therapeutics.

When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?

Plus Therapeutics’s Q1 earnings are confirmed for Tuesday, April 30, 2024.

Is Plus Therapeutics (PSTV) going to split?

There is no upcoming split for Plus Therapeutics.

What sector and industry does Plus Therapeutics (PSTV) operate in?

Plus Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-